'Fillers are not a good look': Sienna Miller on why less is more - Schwarzkopf’s new Global Brand Ambassador on her go-to ...

Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin ...

Nu Skin is rated a buy, trading at low multiples with turnaround prospects tied to India expansion and Prysm iO device launch. NUS’s core MLM business faces structural decline, but new product and ...

Psoriasis is a chronic inflammatory skin condition that speeds up skin cell turnover, leading to thick, scaly patches on the skin. These plaques can develop all over the body, including the arms, legs ...

The projected fair value for Nu Skin Enterprises is US$10.00 based on 2 Stage Free Cash Flow to Equity Current share price of US$8.36 suggests Nu Skin Enterprises is potentially trading close to its ...

Glow drops, bronzing lotions and body mousses so you can skip the harmful tanning beds and UV rays.

Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S. small-cap equities ...

Celebrity spray tan artists, content creators, and reality stars share how to achieve the perfect fake tan for spring break.

Beyond bronzing, the “skin-loving” formula contains glycerin to help lock in moisture, ensuring the tan remains comfortable for days. (Alysa advises exfoliating “gently but thoroughly” and avoiding ...

Nu Skin Enterprises’ latest earnings call struck a cautiously optimistic tone, pairing a sharp rebound in profitability and healthier margins with a frank acknowledgment of softer top-line trends and ...

Nu Skin Enterprises, Inc. misses on earnings expectations. Reported EPS is $0.29 EPS, expectations were $0.3. Operator: Good day, and thank you for standing by. Welcome to the Q4 2025 Conference Call.

Shares of Nu Skin Enterprises were lower after the company reported lower revenue in the fourth quarter and guided for further declines, despite swinging to a profit. Shares were down 17% at $8.45 in ...